The "multiburst" mode of bimanual microincision phacoemulsification machines is unsuitable for treating cataracts with a nuclear density of Grade 3 and above, according to study results published in the July 2008 issue of Clinical & Experimental Ophthalmology.
The "multiburst" mode of bimanual microincision phacoemulsification machines is unsuitable for treating cataracts with a nuclear density of Grade 3 and above, according to study results published in the July 2008 issue of Clinical & Experimental Ophthalmology.
Liu Yizhi, MD, PhD of the Zhongshan Ophthalmic Center at Sun Yat-sen University, Guangzhou, China and colleagues assessed the effects on "hard" cataracts of the "multiburst" and "shortburst" settings of the Sovereign phaco machine (AMO) in comparison to the settings on the Whitestar technology platform (AMO).
The differences between the three groups were statistically significant. The ultrasonic power was highest for the Whitestar, followed by Sovereign's shortpulse and then the multiburst setting. The multiburst setting had the highest ultrasonic power release time, effective phaco time and rate of endothelial cell loss; the group displaying the lowest levels of these variables was the Whitestar group. In the multiburst group, there was also one case of wound burn and three eyes displaying abnormal fluctuations in the anterior chamber depth.
Based on these data, the research team concluded that, while Sovereign's multiburst mode was an unreliable method of performing this type of surgery, Whitestar technology had the best results of the study and offers an acceptable alternative.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.